Evidence map›Paper›PMID 36409706›Full record

ArticlePloS one2022

DR4/DQ2 haplotype confers susceptibility to T1DM with early clinical disease onset: A retrospective analysis in a tertiary-care hospital in Italy.

Silvia Ricci, Francesca Perugia, Barbara Piccini, Lorenzo Lodi, Francesco Pegoraro, Mattia Giovannini, Giovanni Rombolà, Giancarlo Perferi, Sonia Toni, Chiara Azzari

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Silvia RicciSection of Pediatrics, Meyer Children's Hospital, Florence, Italy.ORCID 0000-0001-7140-1694
Francesca PerugiaDepartment of Translational Research and the New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Barbara PicciniDiabetology Unit, Meyer University Children's Hospital, Florence, Italy.
Lorenzo LodiSection of Pediatrics, Meyer Children's Hospital, Florence, Italy.
Francesco PegoraroSection of Pediatrics, Meyer Children's Hospital, Florence, Italy.ORCID 0000-0002-4954-5744
Mattia GiovanniniSection of Pediatrics, Meyer Children's Hospital, Florence, Italy.
Giovanni RombolàGenetics Diagnostics-Laboratory of Immunogenetics and Transplant Biology, Careggi Hospital, Florence, Italy.
Giancarlo PerferiSection of Pediatrics, Meyer Children's Hospital, Florence, Italy.
Sonia ToniDiabetology Unit, Meyer University Children's Hospital, Florence, Italy.
Chiara AzzariSection of Pediatrics, Meyer Children's Hospital, Florence, Italy.
Meyer Children's Hospital · ITAzienda Ospedaliero-Universitaria Careggi · ITUniversity of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionT1DM is the most frequent form of diabetes in children. It has a multifactorial pathogenesis in which genetic, environmental and immunological factors are involved. Among genetic explanations a major role is attributed to second class HLA genes, with the greatest risk associated with the simultaneous presence of the haplotypes DR3DQ2 and DR4DQ8. Based on results obtained in other countries, the aim of this research is to verify a possible association between the haplotype DRB1 * 04: 05-DQA1 * 03-DQB1 * 02 and the onset of T1DM among Italian children with possible genotype-phenotype correlations. Greater knowledge of genes which increase or decrease susceptibility is important for genome analysis. MATERIALS AND

methods165 patients with type 1 diabetes treated at the Diabetology Unit of the Meyer Children's University Hospital, were clinically analyzed. Data relating to age at diagnosis, pancreatic anti-beta cell autoimmunity, comorbidities with date of diagnosis and family history were retrospectively collected from medical data. A case-control study was conducted to investigate the HLA types of the patients compared to a control group of 819 Tuscan donors enrolled in the National Bone Marrow Donor Register. Typing was carried out using the Eurospital "DIABEGEN" kit, currently in use at the immunology laboratory of the Meyer Children's University Hospital.

resultsMean age at diagnosis was 9.3 years; most children (97%) had anti-pancreatic beta cell autoimmunity; the anti-insulin antibody (IAA) was more frequent among children with early clinical disease onset (0-5 years of age). From the case control comparison performed on HLA typing, it emerged that the greatest risk for the development of type 1 diabetes is conferred by the haplotypes DR3DQ2 and DR4DQ8, but in addition to these haplotypes, already known in other countries, we identified another haplotype, DR4DQ2 (DRB1 * 04: 05-DQA1 * 03-DQB1 * 02) which appears to predispose children to type 1 diabetes (p value 2.80E-08) and it is associated with early clinical disease onset (p-value = 0.002).

conclusionsWe report a new haplotype which increases susceptibility to type 1 diabetes among Italian children and which is associated with early clinical disease onset. Given the central role attributed to genetic factors in the pathogenesis of T1DM and to the II class HLA genes, this new haplotype ought to be recognized as a risk factor and included in tests routinely carried out to identify patients with a genetic predisposition to type I diabetes in Italy. These findings could have practical implications in research and prevention programs.

Indexed as

Diabetes Mellitus, Type 1HLA-DQ AntigensCase-Control StudiesHaplotypesHLA-DR4 AntigenHumansRetrospective StudiesTertiary Care CentersHLA-DQ AntigensHLA-DR4 Antigen

Identifiers

PMID36409706
PMCPMC9678300
OpenAlexW4309495967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.